PropertyValue
?:abstract
  • Three recent papers published in Nature, Science and Cell, all present clear evidence that there is cross-reactive T-cell immunity between human coronaviruses (229E, NL63, OC43, and HKU1), linked with the common cold, and SARS-CoV-2, the causative agent of COVID-19. Can we use this information to design and build a new vaccine based on the less pathogenic, common cold coronaviruses, for the prevention of COVID-19? If we look at the history of medicine and vaccine development, from the point of view of Edward Jenner, the answer just might be yes.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.18632/aging.104166
?:journal
  • Aging_(Albany_NY)
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/86658dc4a2f51e772a13b1051199b416dc5942bb.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7732292.xml.json
?:pmcid
?:pmid
?:pmid
  • 33049711.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Using the common cold virus as a naturally occurring vaccine to prevent COVID-19: Lessons from Edward Jenner
?:type
?:year
  • 2020-10-13

Metadata

Anon_0  
expand all